NCT04524273 2026-03-10
MINT
Amgen
Phase 3 Active not recruiting
Clinical Trials
12 trialsNCT04951622 2026-03-03
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
Phase 3 Recruiting
NCT04818671 2026-01-22
ADAPTSC+
argenx
Phase 3 Completed
NCT05150210 2025-12-23
SP Thoracic IDE Study
Intuitive Surgical
Phase NA Active not recruiting
NCT05681715 2025-11-06
A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
UCB Pharma
Phase 3 Completed
NCT05230082 2025-09-18
Acupuncture in Myasthenia Gravis (AcuMG)
HealthPartners Institute
Phase NA Completed
NCT05132569 2025-09-09
URSA
Sanofi
Phase 3 Terminated
NCT05514873 2025-09-03
An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
UCB Pharma
Phase 3 Completed
NCT04115293 2025-07-16
RAISE
UCB Pharma
Phase 3 Completed
NCT03818204 2025-06-13
Clinical Trial to Improve the Magnetic Levator Prosthesis
Massachusetts Eye and Ear Infirmary
Phase NA Completed
NCT04678115 2025-04-22
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
Massachusetts Eye and Ear Infirmary
Phase NA Completed
NCT04650854 2025-04-18
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed